These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27538645)

  • 21. Lack of association between UCHL1 S18Y gene polymorphism and Parkinson's disease in the Asian population: a meta-analysis.
    Sun S; Zhao Y; Jin G; Kang H
    Neurol Sci; 2014 Dec; 35(12):1867-76. PubMed ID: 25354657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.
    Wu YL; Ding XX; Sun YH; Yang HY; Sun L
    J Neurol Sci; 2013 Dec; 335(1-2):14-21. PubMed ID: 24064257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis.
    Zintzaras E; Hadjigeorgiou GM
    J Hum Genet; 2005; 50(11):560-566. PubMed ID: 16172806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis.
    Yuan Y; Tong Q; Zhou X; Zhang R; Qi Z; Zhang K
    Gene; 2013 Jul; 524(2):133-8. PubMed ID: 23628795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between alpha-synuclein (SNCA) rs11931074 variability and susceptibility to Parkinson's disease: an updated meta-analysis of 41,811 patients.
    Du B; Xue Q; Liang C; Fan C; Liang M; Zhang Y; Bi X; Hou L
    Neurol Sci; 2020 Feb; 41(2):271-280. PubMed ID: 31758346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.
    Xiao Z; Yin G; Ni Y; Qu X; Wu H; Lu H; Qian S; Chen L; Li J; Qiu H; Miao K
    Biomed Pharmacother; 2017 Nov; 95():743-748. PubMed ID: 28888211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A PRISMA-compliant meta-analysis of MDR1 polymorphisms and idiopathic nephrotic syndrome: Susceptibility and steroid responsiveness.
    Han SS; Xu YQ; Lu Y; Gu XC; Wang Y
    Medicine (Baltimore); 2017 Jun; 96(24):e7191. PubMed ID: 28614261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.
    Quan W; Li J; Liu L; Zhang Q; Qin Y; Pei X; Chen J
    Neurol Sci; 2022 May; 43(5):3145-3152. PubMed ID: 34845561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between SNCA rs356220 polymorphism and Parkinson's disease: A meta-analysis.
    Bi M; Kang S; Du X; Jiao Q; Jiang H
    Neurosci Lett; 2020 Jan; 717():134703. PubMed ID: 31863812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibility : a meta-analysis based on 11,339 subjects.
    Zhao L; Li K; Li W; Yang Z
    Tumour Biol; 2013 Jun; 34(3):1949-57. PubMed ID: 23504525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional polymorphisms of the MAO gene with Parkinson disease susceptibility: a meta-analysis.
    Sun YX; Wang XH; Xu AH; Zhao JH
    J Neurol Sci; 2014 Oct; 345(1-2):97-105. PubMed ID: 25066260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.
    Liu H; Liu H; Li T; Cui J; Fu Y; Ren J; Sun X; Jiang P; Yu S; Li C
    Neurosci Lett; 2017 May; 650():25-32. PubMed ID: 28385514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis.
    Gao Z; Fu HJ; Xue JJ; Wu ZX; Zhao LB
    Mol Biol Rep; 2014 Jul; 41(7):4463-74. PubMed ID: 24595449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of rs356219 and rs3822086 polymorphisms with the risk of Parkinson's disease: A meta-analysis.
    Hou B; Zhang X; Liu Z; Wang J; Xie A
    Neurosci Lett; 2019 Sep; 709():134380. PubMed ID: 31325583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Association Between NGFR, ADAM17 Gene Polymorphism, and Parkinson's Disease in the Chinese Han Population.
    Li WW; Shen YY; Chen DW; Li HY; Shi QQ; Mei J; Yang H; Zhou FY; Shi AY; Zhang T; Yao XQ; Xu ZQ; Zeng F; Wang YJ
    Neurotox Res; 2019 Oct; 36(3):463-471. PubMed ID: 30941646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis.
    Lu PH; Wei MX; Yang J; Liu X; Tao GQ; Shen W; Chen MB
    Breast Cancer Res Treat; 2011 Jan; 125(2):537-43. PubMed ID: 20625815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D receptor rs2228570 polymorphism and Parkinson's disease risk in a Chinese population.
    Hu W; Wang L; Chen B; Wang X
    Neurosci Lett; 2020 Jan; 717():134722. PubMed ID: 31877334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between PARK16 and Parkinson's disease: A meta-analysis.
    He T; Wang J; Wang X; Deng W; Jiang H; Xie J; Sun P
    Neurosci Lett; 2017 Sep; 657():179-188. PubMed ID: 28807727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci.
    Tang S; Yao B; Li N; Lin S; Huang Z
    Cell Physiol Biochem; 2018; 51(1):411-428. PubMed ID: 30453293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between Glutathione S-transferase M1/Glutathione S-transferase T1 polymorphisms and Parkinson's disease: a meta-analysis.
    Wang T; Wang B
    J Neurol Sci; 2014 Mar; 338(1-2):65-70. PubMed ID: 24382428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.